Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Esophagus
Status:
Completed
Trial end date:
2003-12-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Combining more than one drug may kill more tumor cells.
PURPOSE: Phase II trial to study the effectiveness of combining irinotecan and cisplatin in
treating patients who have locally advanced unresectable or metastatic cancer of the
esophagus that has not been previously treated.